GP Profile: Egeria
Egeria is currently investing from its fifth fund and announced the opening of its DACH office in April 2020 amid the coronavirus lockdown. Hannes Rumer, a partner in the new Munich office, speaks to Unquote about the GP’s strategy and deal pipeline for the DACH region
More on GPs
Eurazeo raises €2.8bn in 2020
Amount includes the capital raised by Eurazeo Growth III, which has now collected more than €500m
ICG hires Bridge Valley's life sciences investment team
Allan Marchington, who will become head of ICG life sciences, says the team has a strong pipeline
Eight Roads promotes Cornet to partner
Principal Lucile Cornet joined Eight Roads Ventures as an associate in 2016
CapMan boosts wealth advisory team
Nordic firm has appointed four people across wealth advisory, alternative investment and marketing
Latest News
LP Profile: IMCO
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Elbrus holds first close on $260m for third fund – report
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018